Cancer Advances
Subscribe:
Featured Episode
Impact of p53 in Acute Lymphoblastic Leukemia (ALL)
Hematologist and medical oncologist, Moaath Mustafa Ali, MD, MPH joins the Cancer Advances Podcast to talk about the impact of p53 mutations in patients with acute lymphoblastic leukemia (ALL). Listen as Dr. Mustafa Ali explains findings from a large real-world dataset, challenges in data collection, and how these insights may guide future treatment strategies.
Play NowAll Cancer Advances Episodes
June 5, 2025
A Closer Look at ASCO's Transoral Robotic Surgery Guidelines in HPV+ Oropharyngeal Cancer
Jamie Ku, MD, Director of the Head and Neck Robotic Surgery Program at Cleveland Clinic joins the Cancer Advances Podcast to discuss the newly released ASCO clinical practice guidelines for transoral robotic surgery (TORS) in patients with HPV-positive oropharyngeal cancer. Listen as Dr. Ku, who co-chaired the ASCO expert panel, provides insight into the multidisciplinary process behind the guidelines, outlines key recommendations for patient selection and explains the role of TORS as a minimally invasive surgical approach.
Play NowMay 29, 2025
Setting the Standard: Cleveland Clinic Children’s First-in-Nation Pediatric Cancer Accreditation
Matteo Trucco, MD, Director of the Children’s Cancer Innovative Therapy Program, joins the Cancer Advances Podcast to discuss the Cleveland Clinic Children's recent recognition as the first center in the nation to receive pediatric cancer subcommittee accreditation from the Commission on Cancer. Learn how this milestone is not only advancing pediatric cancer care at Cleveland Clinic but also shaping national benchmarks for multidisciplinary pediatric oncology programs.
Play NowMay 22, 2025
Predicting Gastric Cancer Risk: A New EHR-Based Model
Chair of the Department of Gastroenterology, Hepatology and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss her team’s innovative work using electronic health records (EHR) to develop a predictive model for noncardia gastric cancer. Listen as Dr. Kim explains how the model uses common clinical variables to flag high-risk patients who may benefit from endoscopic screening.
Play NowMay 15, 2025
Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)
Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.
Play Now
